162 related articles for article (PubMed ID: 24973953)
1. Clinical importance and therapeutic implication of E-cadherin gene methylation in human ovarian cancer.
Wu X; Zhuang YX; Hong CQ; Chen JY; You YJ; Zhang F; Huang P; Wu MY
Med Oncol; 2014 Aug; 31(8):100. PubMed ID: 24973953
[TBL] [Abstract][Full Text] [Related]
2. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
3. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
4. [Study on promoter methylation status of E-cadherin gene in nasopharyngeal carcinoma cell lines].
Hong CQ; Ran YG; Chen JY; Wu X; You YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):532-6. PubMed ID: 21055032
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
Wang Z; Li M; Lu S; Zhang Y; Wang H
Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
[TBL] [Abstract][Full Text] [Related]
7. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
8. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
Jin P; Song Y; Yu G
Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
[TBL] [Abstract][Full Text] [Related]
9. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
[TBL] [Abstract][Full Text] [Related]
10. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
11. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
[TBL] [Abstract][Full Text] [Related]
12. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
Zhang S; Wei L; Zhang A; Zhang L; Yu H
OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
[TBL] [Abstract][Full Text] [Related]
13. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer.
Yuecheng Y; Hongmei L; Xiaoyan X
Clin Exp Metastasis; 2006; 23(1):65-74. PubMed ID: 16826427
[TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.
Takada T; Yagi Y; Maekita T; Imura M; Nakagawa S; Tsao SW; Miyamoto K; Yoshino O; Yasugi T; Taketani Y; Ushijima T
Cancer Sci; 2004 Sep; 95(9):741-4. PubMed ID: 15471560
[TBL] [Abstract][Full Text] [Related]
16. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
17. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
18. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.
Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA
BMC Mol Biol; 2014 Oct; 15():24. PubMed ID: 25294702
[TBL] [Abstract][Full Text] [Related]
19. TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.
Wang N; Zhang H; Yao Q; Wang Y; Dai S; Yang X
J Exp Clin Cancer Res; 2012 Jan; 31(1):6. PubMed ID: 22248469
[TBL] [Abstract][Full Text] [Related]
20. [Effect of 5-Aza-CdR on expression and methylation of E-cadherin gene in human colon carcinoma cells].
Ren JZ; Huo JR
Chin J Cancer; 2010 Jan; 29(1):38-42. PubMed ID: 20038309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]